Cargando…

Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer

Triple negative breast cancer (TNBC) is characterized by clinical aggressiveness, lack of recognized target therapy, and a dismal patient prognosis. Several studies addressed genomic changes occurring during neoadjuvant chemotherapy (NAC) focusing on somatic variants, but without including copy numb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silvestri, Marco, Dugo, Matteo, Vismara, Marta, De Cecco, Loris, Lanzoni, Davide, Vingiani, Andrea, Folli, Secondo, De Santis, Maria Carmen, de Braud, Filippo, Pruneri, Giancarlo, Di Cosimo, Serena, Cappelletti, Vera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795239/ https://www.ncbi.nlm.nih.gov/pubmed/35087134 http://dx.doi.org/10.1038/s41598-022-05502-6

Ejemplares similares

Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy
por: Di Cosimo, Serena, et al.
Publicado: (2019)

Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy
por: Ortolan, E., et al.
Publicado: (2021)

Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer
por: Reduzzi, Carolina, et al.
Publicado: (2021)

Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world
por: Di Cosimo, Serena, et al.
Publicado: (2022)

Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma
por: Silvestri, Marco, et al.
Publicado: (2023)

Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNA
por: La Rocca, E., et al.
Publicado: (2022)

Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients
por: Silvestri, Marco, et al.
Publicado: (2021)

A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer
por: Reduzzi, Carolina, et al.
Publicado: (2019)

Concomitant medications and circulating tumor cells: friends or foes?
por: Di Cosimo, Serena, et al.
Publicado: (2023)

Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study
por: Di Cosimo, Serena, et al.
Publicado: (2019)

Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients
por: Ligorio, Francesca, et al.
Publicado: (2021)

End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
por: Di Cosimo, Serena, et al.
Publicado: (2023)

Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study
por: Dugo, Matteo, et al.
Publicado: (2019)

Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma
por: Minna, Emanuela, et al.
Publicado: (2020)

Association of FOSL1 copy number alteration and triple negative breast tumors
por: Serino, Leandro Tamião Rodrigues, et al.
Publicado: (2019)

Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
por: Loi, Sherene, et al.
Publicado: (2022)

Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors
por: Minna, Emanuela, et al.
Publicado: (2023)

Medullary Thyroid Carcinoma Mutational Spectrum Update and Signaling-Type Inference by Transcriptional Profiles: Literature Meta-Analysis and Study of Tumor Samples
por: Minna, Emanuela, et al.
Publicado: (2022)

Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer
por: Callari, Maurizio, et al.
Publicado: (2018)

Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression
por: Cappelletti, Vera, et al.
Publicado: (2020)

Metabolic Footprints and Molecular Subtypes in Breast Cancer
por: Cappelletti, Vera, et al.
Publicado: (2017)

Stromal Activation by Tumor Cells: An in Vitro Study in Breast Cancer
por: Merlino, Giuseppe, et al.
Publicado: (2016)

The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial–mesenchymal transition, and immune response
por: Devecchi, Andrea, et al.
Publicado: (2018)

Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors
por: Vernieri, Claudio, et al.
Publicado: (2019)

Psychosocial factors associated with workability after surgery in cancer survivors: An explorative study
por: Silvaggi, Fabiola, et al.
Publicado: (2023)

Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial
por: Gennaro, Massimiliano, et al.
Publicado: (2022)

Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications
por: Zattarin, Emma, et al.
Publicado: (2020)

Direct and indirect effects of COVID-19 on short-term mortality of breast cancer patients
por: Di Cosimo, Serena, et al.
Publicado: (2023)

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit
por: Triulzi, Tiziana, et al.
Publicado: (2018)

miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma
por: Minna, Emanuela, et al.
Publicado: (2014)

Microenvironment and tumor inflammatory features improve prognostic prediction in gastro‐entero‐pancreatic neuroendocrine neoplasms
por: Milione, Massimo, et al.
Publicado: (2019)

Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care
por: Vingiani, Andrea, et al.
Publicado: (2023)

Gene expression-based dissection of inter-histotypes, intra-histotype and intra-tumor heterogeneity in pediatric tumors
por: Ciceri, Sara, et al.
Publicado: (2022)

Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer
por: Castagnoli, Lorenzo, et al.
Publicado: (2023)

Integrated transcriptional‐phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients
por: Rinchai, Darawan, et al.
Publicado: (2021)

Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model
por: Azzollini, Jacopo, et al.
Publicado: (2022)

Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration
por: Triulzi, Tiziana, et al.
Publicado: (2015)

Optimizing checkpoint inhibitors therapy for relapsed or progressive classic Hodgkin lymphoma by multiplex immunohistochemistry of the tumor microenvironment
por: Carbone, Antonino, et al.
Publicado: (2019)

Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma
por: Alfieri, Salvatore, et al.
Publicado: (2020)

Impact of biospecimens handling on biomarker research in breast cancer
por: De Cecco, Loris, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_lu25e863tli928hefbp8498bhl